Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
ACAD: ACADIA Pharmaceuticals Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
ACAD
The Story
ACAD
Loading chart data...
Current State
Balance holding
The verdict
Good business
No data
Operating margin
7.4%
ROIC
6.2%
Financially safe
Stretched
Debt / equity
0.04×
Interest coverage
0.0×
Current ratio
3.59×
Valuation
Unrated
P/E ratio
11.6×
ACADIA Pharmaceuticals Inc.
ACAD
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
ACADIA Pharmaceuticals Inc.
ACAD
NASDAQ
·
USD
·
Closed
$25.87
−2.56%
$25.87
−$0.68 (2.56%)
52W Range
71th
pctl
Volume
0.92×
avg
Mkt Cap
4.43B
USD
P/E
11.6
TTM
Div Yield
–
ann
52W Range
71th
pctl
Volume
0.92×
avg
Market Cap
4.43B
USD
P/E Ratio
11.6
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings